Market Tracker

09/19 6:35pm ET

Actavis PLC (NYSE:ACT)

241.81
Data as of Sep 19
 +3.88 / +1.63%
Today’s Change
135.50
Today|||52-Week Range
245.50
+43.93%
Year-to-Date

Today’s Trading

Previous close237.93
Today’s open239.49
Day’s range236.41 - 245.50
Volume3,676,989
Average volume (3 months)2,305,152
Market cap$63.9B
Dividend yield--
Data as of 4:07pm ET, 09/19/2014

Growth & Valuation

Earnings growth (last year)-793.42%
Earnings growth (this year)+39.89%
Earnings growth (next 5 years)+18.86%
Revenue growth (last year)+46.71%
P/E ratioNM
Price/Sales2.75
Price/Book4.42

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories-0.10-0.23%
LLYEli Lilly and Co-0.06-0.09%
CELGCelgene Corp+0.58+0.62%
SHPGShire PLC-2.33-0.89%
Data as of 4:14pm ET, 09/19/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)$3.10
Annual revenue (last year)$8.7B
Annual profit (last year)-$750.4M
Net profit margin-8.65%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts